Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj Das

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
American Heart Journal|October 8, 2013
Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trialColin Berry, Jamie Layland, Arvind Sood, et al.
CVIR Endovascular|October 20, 2020
Role of interventional radiology in line insertion on intensive care during the Covid-19 pandemicTom Cavenagh, Sofia Katsari, Bhavin Kawa, et al.
European Heart Journal|September 3, 2014
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trialJamie Layland, Keith G Oldroyd, Nick Curzen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 9, 2026
Sub-Unit-Cell Logic Governs Transport in TPMS ArchitecturesHaozhang Zhong, Yipei He, Jiaxuan Wang, et al.
BJU International|September 22, 2022
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathwayDavid Eldred-Evans, Martin J Connor, Mariana Bertoncelli Tanaka, et al.
European Heart Journal|December 8, 2025
Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trialColin Berry, Bethany Stanley, Patrycja Duklas, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
American Heart Journal|October 8, 2013
Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trialColin Berry, Jamie Layland, Arvind Sood, et al.
CVIR Endovascular|October 20, 2020
Role of interventional radiology in line insertion on intensive care during the Covid-19 pandemicTom Cavenagh, Sofia Katsari, Bhavin Kawa, et al.
European Heart Journal|September 3, 2014
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trialJamie Layland, Keith G Oldroyd, Nick Curzen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 9, 2026
Sub-Unit-Cell Logic Governs Transport in TPMS ArchitecturesHaozhang Zhong, Yipei He, Jiaxuan Wang, et al.
BJU International|September 22, 2022
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathwayDavid Eldred-Evans, Martin J Connor, Mariana Bertoncelli Tanaka, et al.
European Heart Journal|December 8, 2025
Fractional flow reserve vs angiography in non-ST- elevation myocardial infarction: long-term results of the FAMOUS-NSTEMI trialColin Berry, Bethany Stanley, Patrycja Duklas, et al.
Cost Effectiveness and Resource Allocation : C/E|November 19, 2015
Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methodsJulian Nam, Andrew Briggs, Jamie Layland, et al.
Pageof 5